Toggle navigation
Home
Search
Services
Blog
Contact
About
Design/Synthesis of Oral Galanin Agonists/Antagonists
Manfred, Wolff
Immunopharmaceutics, Inc., San Diego, CA, United States
Search 3 grants from Wolff Manfred
Search grants from Immunopharmaceutics, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Conference on Advanced Psychometric Methods in Cognitive Aging Research
Development of Animal Models of Anti-MuSK Myasthenia
Carrier Mediated Uptake of ABeta In Vivo &In Vitro
Clinical Trials in Schizophrenia - Molecular Approaches
Shear Banding and Shear Fracture of Polycarbonate
Recently added grants:
Medium-chain acyl-coenzyme A dehydrogenase as an essential feeder of glioblastoma multiforme
Regulation of TAL1/SCL in T-Cell Leukemia
Bionanotechnology approach for treatment of lung cancer
A personalized approach to skin cancer prevention among adolescents
Cognitive Recovery With Cannabis Abstinence Among High School-Aged Adolescents
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43MH030021-002
Application #
3667508
Study Section
Project Start
1993-09-01
Project End
1994-04-15
Budget Start
1994-03-01
Budget End
1994-04-15
Support Year
Fiscal Year
1994
Total Cost
Indirect Cost
Institution
Name
Immunopharmaceutics, Inc.
Department
Type
DUNS #
City
San Diego
State
CA
Country
United States
Zip Code
92127
Related projects
NIH 1994
N43 MH
Design/Synthesis of Oral Galanin Agonists/Antagonists
Manfred, Wolff / Immunopharmaceutics, Inc.
NIH 1993
N43 MH
Design/Synthesis of Oral Galanin Agonists/Antagonists
Wolff, Manfred E. / Immunopharmaceutics, Inc.
Comments
Be the first to comment on Wolff Manfred's grant